Nighthawk Biosciences, Inc. (SCPX) Press Releases https://www.nighthawkbio.com/investors-news/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/nighthawkbio/files/theme/images/logo-sm.png Nighthawk Biosciences, Inc. Logo /investors-news Equisolve Investor Relations Suite <![CDATA[NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today]]> https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/740/nighthawk-biosciences-completes-name-change-to-scorpius Tue, 06 Feb 24 08:00:00 -0500 https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/740/nighthawk-biosciences-completes-name-change-to-scorpius <![CDATA[NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer]]> https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/739/nighthawks-scorpius-biomanufacturing-subsidiary Thu, 01 Feb 24 08:00:00 -0500 https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/739/nighthawks-scorpius-biomanufacturing-subsidiary <![CDATA[NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note]]> https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/738/nighthawk-receives-proceeds-of-3-25-million-in-connection Tue, 30 Jan 24 08:00:00 -0500 https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/738/nighthawk-receives-proceeds-of-3-25-million-in-connection <![CDATA[NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program]]> https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/737/nighthawks-scorpius-biomanufacturing-subsidiary-awarded Thu, 25 Jan 24 08:30:00 -0500 https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/737/nighthawks-scorpius-biomanufacturing-subsidiary-awarded <![CDATA[NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client]]> https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/736/nighthawks-scorpius-biomanufacturing-subsidiary Tue, 16 Jan 24 08:30:00 -0500 https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/736/nighthawks-scorpius-biomanufacturing-subsidiary <![CDATA[NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO]]> https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/735/nighthawk-biosciences-announces-planned-name-change-to Mon, 08 Jan 24 08:30:00 -0500 https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/735/nighthawk-biosciences-announces-planned-name-change-to <![CDATA[NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National University]]> https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/734/nighthawk-biosciences-commences-work-on Wed, 03 Jan 24 08:30:00 -0500 https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/734/nighthawk-biosciences-commences-work-on <![CDATA[NightHawk Biosciences Announces Completion of Demonstration Run for a Top-Tier NIH and DTRA Funded Research University]]> https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/733/nighthawk-biosciences-announces-completion-of-demonstration Thu, 21 Dec 23 08:30:00 -0500 https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/733/nighthawk-biosciences-announces-completion-of-demonstration <![CDATA[NightHawk Biosciences Announces Major Milestone with Completion of Manufacturing Run for a Premier U.S.-Based Biopharmaceutical Company]]> https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/732/nighthawk-biosciences-announces-major-milestone-with Mon, 18 Dec 23 08:30:00 -0500 https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/732/nighthawk-biosciences-announces-major-milestone-with <![CDATA[NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets]]> https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/731/nighthawk-biosciences-announces-strategic-shift-into-a Tue, 12 Dec 23 08:30:00 -0500 https://www.nighthawkbio.com/investors-news/news-events/press-releases/detail/731/nighthawk-biosciences-announces-strategic-shift-into-a